Brian Gabrielli
Papers
1
Total Citations
51
H-Index
1
About
Brian Gabrielli is a leading cancer biologist whose research centers on cell cycle control, genomic stability, and the mechanisms of action of anti-cancer drugs. His major contributions include pioneering the use of high-throughput lentiviral overexpression screening to functionally annotate the human genome, a platform that has become a critical tool for identifying genes involved in cancer progression and drug resistance. His most cited work, "A High-Throughput Platform for Lentiviral Overexpression Screening of the Human ORFeome" (2011, 51 citations), exemplifies his innovative approach to systematically probing gene function. Gabrielli’s studies have significantly advanced our understanding of how cell cycle checkpoints, particularly the G2/M phase, are regulated and how their disruption can be exploited therapeutically. His research has directly informed the development of novel combination therapies, such as using Chk1 inhibitors to sensitize cancer cells to DNA-damaging agents. With a sustained impact on both fundamental cell biology and translational oncology, Gabrielli’s work continues to shape how researchers approach functional genomics and targeted cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1